A phase 1 study of a vaccine targeting preferentially expressed antigen in melanoma and prostate-specific membrane antigen in patients with advanced solid tumors (Q37007590)

From Wikidata
Jump to navigation Jump to search
scientific article published on September 2011
edit
Language Label Description Also known as
English
A phase 1 study of a vaccine targeting preferentially expressed antigen in melanoma and prostate-specific membrane antigen in patients with advanced solid tumors
scientific article published on September 2011

    Statements

    A phase 1 study of a vaccine targeting preferentially expressed antigen in melanoma and prostate-specific membrane antigen in patients with advanced solid tumors (English)
    Jeffrey S Weber
    Nicholas J Vogelzang
    Marc S Ernstoff
    Oscar B Goodman
    John L Marshall
    David C Diamond
    Mihail Obrocea

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit